Martin, P.M.

patient cancer tumor breast level breast cancer activity lymph prognostic treatment base model model dataset status study analysis urokinase-type plasminogen activator factor lymph node status curve value adjuvant plasminogen lymph node-positive patients tk activity survival month activator therapy node-negative <.001 response breast cancer patients lymph node-negative patients prognostic value tamoxifen variable hormone-receptor status cancer institute chemotherapy prognostic factors result adjuvant treatment inhibitor multivariable 5- fu assay table lymph node-negative protein grade urokinase-type tamoxifen treatment prognosis tk activity levels number thymidine group prognostic variables kinase synthesis disease pathway 10 years menopausal status analyses activity levels ts activity histologic grade thymidine kinase hazard effect node-positive institute hormone-receptor tumor tk activity tumor levels prognostic score marker article